Global Recombinant Cell Culture Supplements Market Report and Forecast 2023-2031

Global Recombinant Cell Culture Supplements Market Report and Forecast 2023-2031


Global Recombinant Cell Culture Supplements Market Outlook

The global recombinant cell culture supplements market was valued at USD 489.3 million in 2022, driven by the increasing demand for cell-based therapies across the globe. The market size is anticipated to grow at a CAGR of 7.7% during the forecast period of 2023-2031 to achieve a value of USD 951.3 million by 2031.

Recombinant Cell Culture Supplements: Introduction

Recombinant cell culture supplements play a crucial role in the development and growth of cells in laboratory settings. These supplements provide essential nutrients, growth factors, and other bioactive molecules necessary for optimal cell culture conditions. They are commonly used in various fields such as biopharmaceutical production, regenerative medicine, and research applications.

The introduction of recombinant cell culture supplements has revolutionized cell culture techniques by offering enhanced performance, consistency, and reproducibility compared to traditional animal-derived supplements. These products are derived from recombinant DNA technology, where specific genes are inserted into host cells to produce desired proteins or growth factors.

Key Trends in the Recombinant Cell Culture Supplements Market

One of the key trends in the field of recombinant cell culture supplements is the shift towards serum-free and animal component-free formulations. Traditional cell culture supplements often contain serum derived from animal sources, which can introduce variability and potential risks such as contamination and transmission of infectious agents. Serum-free and animal component-free supplements provide a safer and more controlled environment for cell culture, ensuring the reproducibility of results.

Overall, the field of recombinant cell culture supplements is witnessing a shift towards serum-free and animal component-free formulations, customization for specific cell types or applications, increased focus on quality control and regulatory compliance, and integration with advanced cell culture technologies. These trends reflect the ongoing efforts to improve cell culture techniques, enhance reproducibility, and meet the evolving needs of various industries relying on cell-based research and production.

Recombinant Cell Culture Supplements Market Segmentations

Market Breakup by Product Type
  • Recombinant Albumin (rAlbumin)
  • Recombinant Insulin (rInsulin)
  • Recombinant Epidermal Growth Factor (rEGF)
  • Recombinant Interleukin Growth Factor (rILGF)
  • Recombinant Transferrin (rTransferrin)
  • Recombinant Trypsin (rTrypsin)
  • Recombinant Insulin-like Growth Factor (rIGF)
  • Recombinant Stem Cell Factor (rSCF)
  • Recombinant Aprotinin (rAprotinin)
  • Recombinant Lysozyme (rLysozyme)
  • Others
  • Recombinant Transforming Growth Factor (rTGF)
  • Recombinant Insulin-Transferrin-Selenium-Ethanolamine (rITSE)
  • Recombinant Platelet-Derived Growth Factor (rPDGF)
  • Recombinant Leukemia Inhibitory Factor (rLIF)
  • Others
Market Breakup by Application
  • Regenerative Medicine
  • Stem Cell Therapies
  • Cell Therapies
  • Gene Therapies
  • Bio-Production
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Hormones
  • Vaccines
  • Other Biological Products
Market by Expression System
  • Mammalian Expression System
  • E. coli Expression System
  • Yeast Expression System
  • Others
Market Breakup by End User
  • Academic and Research Institutions
  • Biotechnology and Pharmaceutical Companies
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Recombinant Cell Culture Supplements Market Scenario

The market for recombinant cell culture supplements is experiencing significant growth and is driven by various factors such as the increasing demand for cell-based therapies, advancements in biopharmaceutical production, and the rising focus on precision medicine and personalized therapies. These supplements play a crucial role in providing the necessary components for optimal cell growth, viability, and productivity in various applications.

The market is witnessing a shift towards serum-free and animal component-free supplements, driven by the need for safer and more standardized cell culture conditions. This shift is particularly prominent in industries such as biopharmaceuticals, where stringent quality control and regulatory compliance are essential. Serum-free and animal component-free supplements offer improved reproducibility, reduced risk of contamination, and better control over cell culture parameters.

Overall, the market for recombinant cell culture supplements is poised for significant growth, driven by the increasing demand for cell-based therapies, advancements in biopharmaceutical production, customization for specific cell types and applications, adoption of advanced cell culture technologies, and expanding geographical presence.

Recombinant Cell Culture Supplements Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Abcam plc.
  • Corning Incorporated
  • BBI Solutions OEM Limited
  • FUJIFILM Irvine Scientific, Inc.
  • Gemini Bioproducts, LLC
  • HiMedia Laboratories, LLC
  • Kingfisher Biotech, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Novus Biologicals, LLC
  • Thermo Fisher Scientific Inc.
  • InVitria
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Recombinant Cell Culture Supplements Market Overview
3.1 Global Recombinant Cell Culture Supplements Market Historical Value (2016-2022)
3.2 Global Recombinant Cell Culture Supplements Market Forecast Value (2023-2031)
4 Global Recombinant Cell Culture Supplements Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Recombinant Cell Culture Supplements Market Segmentation
5.1 Global Recombinant Cell Culture Supplements Market by Product Type
5.1.1 Market Overview
5.1.2 Recombinant Albumin (rAlbumin)
5.1.3 Recombinant Insulin (rInsulin)
5.1.4 Recombinant Epidermal Growth Factor (rEGF)
5.1.5 Recombinant Interleukin Growth Factor (rILGF)
5.1.6 Recombinant Transferrin (rTransferrin)
5.1.7 Recombinant Trypsin (rTrypsin)
5.1.8 Recombinant Insulin-like Growth Factor (rIGF)
5.1.9 Recombinant Stem Cell Factor (rSCF)
5.1.10 Recombinant Aprotinin (rAprotinin)
5.1.11 Recombinant Lysozyme (rLysozyme)
5.1.12 Others
5.1.12.1 Recombinant Transforming Growth Factor (rTGF)
5.1.12.2 Recombinant Insulin-Transferrin-Selenium-Ethanolamine (rITSE)
5.1.12.3 Recombinant Platelet-Derived Growth Factor (rPDGF)
5.1.12.4 Recombinant Leukemia Inhibitory Factor (rLIF)
5.1.12.5 Others
5.2 Global Recombinant Cell Culture Supplements Market by Application
5.2.1 Market Overview
5.2.2 Regenerative Medicine
5.2.2.1 Stem Cell Therapies
5.2.2.2 Cell Therapies
5.2.2.3 Gene Therapies
5.2.3 Bio-Production
5.2.3.1 Monoclonal Antibodies
5.2.3.2 Recombinant Proteins
5.2.3.3 Hormones
5.2.3.4 Vaccines
5.2.3.5 Other Biological Products
5.3 Global Recombinant Cell Culture Supplements Market by Expression System
5.3.1 Market Overview
5.3.2 Mammalian Expression System
5.3.3 E. coli Expression System
5.3.4 Yeast Expression System
5.3.5 Others
5.4 Global Recombinant Cell Culture Supplements Market by End User
5.4.1 Market Overview
5.4.2 Academic and Research Institutions
5.4.3 Biotechnology and Pharmaceutical Companies
5.4.4 Others
5.5 Global Recombinant Cell Culture Supplements Market by Region
5.5.1 Market Overview
5.5.2 North America
5.5.3 Europe
5.5.4 Asia Pacific
5.5.5 Latin America
5.5.6 Middle East and Africa
6 North America Recombinant Cell Culture Supplements Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Recombinant Cell Culture Supplements Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Recombinant Cell Culture Supplements Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Recombinant Cell Culture Supplements Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Recombinant Cell Culture Supplements Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Supplier Landscape
16.1 Abcam plc.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 Corning Incorporated
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 BBI Solutions OEM Limited
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 FUJIFILM Irvine Scientific, Inc.
16.4.1 Financial Analysis
16.4.2 Financial Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Gemini Bioproducts, LLC
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 HiMedia Laboratories, LLC
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Kingfisher Biotech, Inc.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Lonza Group AG
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Merck KGaA
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Novus Biologicals, LLC
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Thermo Fisher Scientific Inc.
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 InVitria
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
17 Global Recombinant Cell Culture Supplements Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings